ASX - By Stock
|
PAB |
Re:
KING OF THE BIOTECH'S
|
|
attaman123
|
9 |
3.8K |
1 |
28/08/17 |
28/08/17 |
ASX - By Stock
|
9
|
3.8K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
KING OF THE BIOTECH'S
|
|
attaman123
|
9 |
3.8K |
0 |
28/08/17 |
28/08/17 |
ASX - By Stock
|
9
|
3.8K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
KING OF THE BIOTECH'S
|
|
attaman123
|
9 |
3.8K |
1 |
16/08/17 |
16/08/17 |
ASX - By Stock
|
9
|
3.8K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Investor Update
|
|
attaman123
|
8 |
3.9K |
0 |
08/08/17 |
08/08/17 |
ASX - By Stock
|
8
|
3.9K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Investor Update
|
|
attaman123
|
8 |
3.9K |
2 |
06/08/17 |
06/08/17 |
ASX - By Stock
|
8
|
3.9K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change in substantial holding
|
|
attaman123
|
6 |
2.4K |
0 |
27/07/17 |
27/07/17 |
ASX - By Stock
|
6
|
2.4K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys' Deoxymab 3E10 patent granted in the U.S.
|
|
attaman123
|
3 |
1.7K |
2 |
20/07/17 |
20/07/17 |
ASX - By Stock
|
3
|
1.7K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys' Deoxymab 3E10 patent granted in the U.S.
|
|
attaman123
|
3 |
1.7K |
1 |
12/07/17 |
12/07/17 |
ASX - By Stock
|
3
|
1.7K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
natural human antibody vs T-cell immunotherapy
|
|
attaman123
|
19 |
7.4K |
1 |
09/07/17 |
09/07/17 |
ASX - By Stock
|
19
|
7.4K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Finance Update
|
|
attaman123
|
9 |
4.3K |
0 |
26/06/17 |
26/06/17 |
ASX - By Stock
|
9
|
4.3K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Finance Update
|
|
attaman123
|
9 |
4.3K |
1 |
24/06/17 |
24/06/17 |
ASX - By Stock
|
9
|
4.3K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Finance Update
|
|
attaman123
|
9 |
4.3K |
1 |
14/06/17 |
14/06/17 |
ASX - By Stock
|
9
|
4.3K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Deoxymab 3E10 lead candidate confirmed
|
|
attaman123
|
4 |
2.5K |
1 |
14/06/17 |
14/06/17 |
ASX - By Stock
|
4
|
2.5K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
natural human antibody vs T-cell immunotherapy
|
|
attaman123
|
19 |
7.4K |
4 |
06/05/17 |
06/05/17 |
ASX - By Stock
|
19
|
7.4K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
natural human antibody vs T-cell immunotherapy
|
|
attaman123
|
19 |
7.4K |
0 |
06/05/17 |
06/05/17 |
ASX - By Stock
|
19
|
7.4K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Finance Update
|
|
attaman123
|
9 |
4.3K |
3 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
9
|
4.3K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
natural human antibody vs T-cell immunotherapy
|
|
attaman123
|
19 |
7.4K |
1 |
17/04/17 |
17/04/17 |
ASX - By Stock
|
19
|
7.4K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Getting into Medical marijuana business
|
|
attaman123
|
36 |
16K |
3 |
23/03/17 |
23/03/17 |
ASX - By Stock
|
36
|
16K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Pab
|
|
attaman123
|
15 |
6.5K |
2 |
15/03/17 |
15/03/17 |
ASX - By Stock
|
15
|
6.5K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 30 September 2016-PAB.AX
|
|
attaman123
|
6 |
3.8K |
2 |
31/10/16 |
31/10/16 |
ASX - By Stock
|
6
|
3.8K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4E and 2016 Annual Report-PAB.AX
|
|
attaman123
|
13 |
5.2K |
0 |
31/08/16 |
31/08/16 |
ASX - By Stock
|
13
|
5.2K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Acquires Novel Assets from Yale University
|
|
attaman123
|
46 |
13K |
3 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
46
|
13K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
1 |
07/07/16 |
07/07/16 |
ASX - By Stock
|
33
|
11K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
A shell company
|
|
attaman123
|
13 |
5.6K |
2 |
05/07/16 |
05/07/16 |
ASX - By Stock
|
13
|
5.6K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
4 |
27/06/16 |
27/06/16 |
ASX - By Stock
|
33
|
11K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2-PAB.AX
|
|
attaman123
|
31 |
8.5K |
1 |
06/06/16 |
06/06/16 |
ASX - By Stock
|
31
|
8.5K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
1 |
03/06/16 |
03/06/16 |
ASX - By Stock
|
33
|
11K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
0 |
03/06/16 |
03/06/16 |
ASX - By Stock
|
33
|
11K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2-PAB.AX
|
|
attaman123
|
31 |
8.5K |
4 |
01/06/16 |
01/06/16 |
ASX - By Stock
|
31
|
8.5K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2-PAB.AX
|
|
attaman123
|
31 |
8.5K |
1 |
28/05/16 |
28/05/16 |
ASX - By Stock
|
31
|
8.5K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2-PAB.AX
|
|
attaman123
|
31 |
8.5K |
2 |
26/05/16 |
26/05/16 |
ASX - By Stock
|
31
|
8.5K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Longest sequence without Trade .. 9 sessions!
|
|
attaman123
|
15 |
5.9K |
0 |
10/05/16 |
10/05/16 |
ASX - By Stock
|
15
|
5.9K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Longest sequence without Trade .. 9 sessions!
|
|
attaman123
|
15 |
5.9K |
4 |
26/04/16 |
26/04/16 |
ASX - By Stock
|
15
|
5.9K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Acquires Novel Assets from Yale University
|
|
attaman123
|
46 |
13K |
0 |
15/04/16 |
15/04/16 |
ASX - By Stock
|
46
|
13K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
1 |
13/04/16 |
13/04/16 |
ASX - By Stock
|
33
|
11K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
1 |
09/04/16 |
09/04/16 |
ASX - By Stock
|
33
|
11K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
1 |
08/04/16 |
08/04/16 |
ASX - By Stock
|
33
|
11K
|
1
|
|
ASX - By Stock
|
PAB |
lupus DNA-damaging antibodies butterfly theory
|
|
attaman123
|
33 |
11K |
0 |
07/04/16 |
07/04/16 |
ASX - By Stock
|
33
|
11K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Hope for 2016
|
|
attaman123
|
14 |
4.7K |
3 |
05/04/16 |
05/04/16 |
ASX - By Stock
|
14
|
4.7K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Acquires Novel Assets from Yale University
|
|
attaman123
|
46 |
13K |
5 |
31/03/16 |
31/03/16 |
ASX - By Stock
|
46
|
13K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Acquires Novel Assets from Yale University
|
|
attaman123
|
46 |
13K |
1 |
30/03/16 |
30/03/16 |
ASX - By Stock
|
46
|
13K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Acquires Novel Assets from Yale University
|
|
attaman123
|
46 |
13K |
5 |
29/03/16 |
29/03/16 |
ASX - By Stock
|
46
|
13K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Acquires Novel Assets from Yale University
|
|
attaman123
|
46 |
13K |
2 |
29/03/16 |
29/03/16 |
ASX - By Stock
|
46
|
13K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
natural human antibody vs T-cell immunotherapy
|
|
attaman123
|
19 |
7.4K |
1 |
17/03/16 |
17/03/16 |
ASX - By Stock
|
19
|
7.4K
|
1
|
|
ASX - By Stock
|
PAB |
natural human antibody vs T-cell immunotherapy
|
|
attaman123
|
19 |
7.4K |
4 |
08/03/16 |
08/03/16 |
ASX - By Stock
|
19
|
7.4K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2015
|
|
attaman123
|
6 |
2.9K |
2 |
01/03/16 |
01/03/16 |
ASX - By Stock
|
6
|
2.9K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2015
|
|
attaman123
|
6 |
2.9K |
5 |
25/02/16 |
25/02/16 |
ASX - By Stock
|
6
|
2.9K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 December 2015
|
|
attaman123
|
26 |
10K |
1 |
31/01/16 |
31/01/16 |
ASX - By Stock
|
26
|
10K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
PAB Board
|
|
attaman123
|
28 |
11K |
4 |
25/12/15 |
25/12/15 |
ASX - By Stock
|
28
|
11K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Seller at 0.9 cents
|
|
attaman123
|
10 |
4.2K |
5 |
10/12/15 |
10/12/15 |
ASX - By Stock
|
10
|
4.2K
|
5
|
|